Trademark: 90173877
Word
OUTPACE BIO
Status Date
Thursday, May 2, 2024
Filing Date
Friday, September 11, 2020
Published for Opposition
Tuesday, September 14, 2021
5 Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; Cells for medical or clinical purposes; viral or non-viral delivery vectors for medical or clinical purposes; proteins for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes, namely, for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; kits comprised of gene delivery vectors and pharmaceutical preparations for medical or clinical purposes, namely, for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; kits comprised of proteins and pharmaceutical preparations for medical or clinical purposes, in particular for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders
42 Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy
Sep 15, 2020
New Application Entered
Oct 19, 2020
New Application Office Supplied Data Entered
Jan 22, 2021
Assigned To Examiner
Feb 3, 2021
Non-Final Action Written
Feb 3, 2021
Non-Final Action E-Mailed
Feb 3, 2021
Notification Of Non-Final Action E-Mailed
May 20, 2021
Teas Response To Office Action Received
May 20, 2021
Correspondence Received In Law Office
May 21, 2021
Teas/Email Correspondence Entered
Jul 6, 2021
Final Refusal Written
Jul 6, 2021
Final Refusal E-Mailed
Jul 6, 2021
Notification Of Final Refusal Emailed
Aug 6, 2021
Examiners Amendment E-Mailed
Aug 6, 2021
Notification Of Examiners Amendment E-Mailed
Aug 6, 2021
Examiners Amendment -Written
Aug 6, 2021
Examiner's Amendment Entered
Aug 6, 2021
Approved For Pub - Principal Register
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Sep 14, 2021
Published For Opposition
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 14, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 14, 2021
Teas Change Of Correspondence Received
Nov 9, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 10, 2022
Teas Change Of Correspondence Received
Mar 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 10, 2022
Teas Change Of Owner Address Received
Mar 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 20, 2022
Sou Teas Extension Received
Apr 20, 2022
Sou Extension 1 Filed
Apr 20, 2022
Sou Extension 1 Granted
Apr 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Sou Teas Extension Received
Nov 7, 2022
Sou Extension 2 Filed
Nov 7, 2022
Sou Extension 2 Granted
Nov 9, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2023
Sou Teas Extension Received
May 2, 2023
Sou Extension 3 Filed
May 2, 2023
Sou Extension 3 Granted
May 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 6, 2023
Sou Teas Extension Received
Nov 6, 2023
Sou Extension 4 Filed
Nov 6, 2023
Sou Extension 4 Granted
Nov 8, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2024
Sou Extension 5 Granted
May 2, 2024
Sou Extension 5 Filed
May 2, 2024
Sou Teas Extension Received
May 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
